Volume 68, Issue 2, Pages (August 2005)

Slides:

Advertisements

Similar presentations

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Advertisements

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.

Beta blockers in the management of chronic kidney disease

Uric Acid and Long-term Outcomes in CKD

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 55, Issue 2, Pages (February 1999)

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Adhesion molecule polymorphisms in chronic renal allograft failure

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

John P. Middleton, Patrick H. Pun Kidney International

Volume 56, Issue 2, Pages (August 1999)

Volume 54, Issue 2, Pages (August 1998)

Predictors of the Risk of Mortality in Neurofibromatosis 2

Malnutrition and inflammation in peritoneal dialysis patients

Effect of Protein Restriction on Serum and Urine Phosphate in the Modification of Diet in Renal Disease (MDRD) Study Britt Newsome, MD, Joachim H. Ix,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Comorbidity and confounding in end-stage renal disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Volume 7, Issue 11, (November 2010)

Volume 70, Issue 11, Pages (December 2006)

Long-term outcomes in nondiabetic chronic kidney disease

Volume 68, Issue 1, Pages (July 2005)

Volume 67, Issue 6, Pages (June 2005)

Pieter Evenepoel, Björn K. Meijers Kidney International

Anemia as a risk factor for cardiovascular disease

Volume 86, Issue 3, Pages (September 2014)

Volume 73, Issue 12, Pages (June 2008)

Volume 61, Issue 1, Pages (January 2002)

Should kidney donors be genotyped for APOL1 risk alleles?

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Methods for guideline development

Cardiovascular disease in pediatric chronic dialysis patients

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease Yoshiki Nishizawa,

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

The global challenge of chronic kidney disease

Volume 62, Issue 6, Pages (December 2002)

Cardiovascular risk factors in chronic kidney disease

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 70, Issue 6, Pages (September 2006)

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Volume 63, Issue 2, Pages (February 2003)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Volume 79, Issue 4, Pages (February 2011)

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 77, Issue 7, Pages (April 2010)

Volume 61, Issue 5, Pages (May 2002)

Volume 62, Issue 4, Pages (October 2002)

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Volume 80, Issue 10, Pages (November 2011)

Is it the low-protein diet or simply the salt restriction?

Volume 64, Issue 4, Pages (October 2003)

Volume 62, Issue 5, Pages (November 2002)

Volume 70, Issue 3, Pages (August 2006)

Fetuin-A is not associated with mortality in chronic kidney disease

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 55, Issue 2, Pages (February 1999)

Volume 77, Issue 11, Pages (June 2010)

Volume 64, Issue 4, Pages (October 2003)

Volume 83, Issue 1, Pages (January 2013)

Reply Journal of Vascular Surgery

Volume 74, Issue 10, Pages (November 2008)

Volume 57, Pages S44-S48 (April 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Sugar-sweetened beverages and chronic disease

Presentation transcript:

Volume 68, Issue 2, Pages 766-772 (August 2005) C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease Vandana Menon, T.O.M. Greene, Xuelei Wang, Arema A. Pereira, Santica M. Marcovina, Gerald J. Beck, John W. Kusek, Alan J. Collins, Andrew S. Levey, Mark J. Sarnak Kidney International Volume 68, Issue 2, Pages 766-772 (August 2005) DOI: 10.1111/j.1523-1755.2005.00455.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Crude all-cause and cardiovascular mortality rates by decile of C-reactive protein. Kidney International 2005 68, 766-772DOI: (10.1111/j.1523-1755.2005.00455.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan-Meier survival curves showed that high C-reactive protein (≥3.0mg/L) was associated with higher all-cause mortality than low C-reactive protein (<3.0mg/L) (log rank test,P = < 0.0001). Kidney International 2005 68, 766-772DOI: (10.1111/j.1523-1755.2005.00455.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan-Meier survival curves showed that high C-reactive protein (≥3.0mg/L) was associated with higher cardiovascular mortality than low C-reactive protein (<3.0mg/L) (log rank test,P = < 0.0001). Kidney International 2005 68, 766-772DOI: (10.1111/j.1523-1755.2005.00455.x) Copyright © 2005 International Society of Nephrology Terms and Conditions